Woman rubbing her eyes

Spot the Ophthalmic Signs & Symptoms of LEMS

ARE THE CHIEF

COMPLAINT
FOR UP TO
MAY AFFECT UP TO

*Based on a single-center observation study in patients with LEMS (n=23).

Chart showing the percentage of LEMS patients with Ophthalmic signs - 26% Ptosis, 8.5% abnormal ocular mobility, 8.0% strabismus, 7% pupillary dysfunction, and 2% dry eye
Chart showing the percentage of LEMS patients with Ophthalmic symptoms - 23% Ptosis, 20.5% diplopia, 14% decreased vision, and 7% dry eye

Background texture of eye
MG
LEMS4,5
Symptoms at onset
  • Rare limb weakness
  • Oculobulbar symptoms in the vast majority of patients
  • Most patients present with mild proximal lower 
extremity weakness
  • Later in the disease, patients may develop oculobulbar symtoms, which may affect up to 51% of people with LEMS
Disease pattern
  • Asymmetric weakness common
  • Craniocaudal progression
  • Symmetric weakness common
  • Caudocranial progression
Oculobulbar
symptoms
  • Often predominate early
  • Ptosis may be severe and asymmetric, worsened with extended upgaze
  • Mild and later in disease course
  • Ptosis mild and symmetric, and may improve after short upgaze
  • Autonomic symptoms (eg, difficulty in focusing sight)
Ophthalmoplegia (internal)
  • Possible but rare
  • Sluggish pupillary reflexes

References: 1. Harms L, Sieb J-P, Williams AE, et al. Long-term disease history, clinical symptoms, health status, and healthcare utilization in patients suffering from Lambert Eaton myasthenic syndrome: results of a patient interview survey in Germany. J Med Econ. 2012;15(3):521-530. 2. Titulaer MJ, Lang B, Verschuuren JJ. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011;10(12):1098-1107. 3. Burns TM, Russell JA, LaChance DH, Jones HR. Oculobulbar involvement is typical with Lambert-Eaton myasthenic syndrome. Ann Neurol. 2003;53:270-273. 4. Costello F, Lee MS. Lambert-Eaton myasthenic syndrome: shaping patient journeys through eye care. MedEdicus. February 11, 2025. Accessed March 23, 2026. https://www.aao.org/Assets/8830465b-c692-42a5-b9e3-bd3625aa0c1c/638775743511930000/march-2025-eyenet-supplement-pdf?inline=1. 5. Wirtz PW, Smallegange TM, Wintzen AR, Verschuuren JJ. Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clin Neurol Neurosurg. 2002;104(4):359-363. 6. Merino-Ramírez MÁ, Bolton CF. Review of the diagnostic challenges of Lambert-Eaton syndrome revealed through three case reports. Can J Neurol Sci. 2016;43(5):635-647. 7. Titulaer MJ, Lang B, Verschuuren JJ. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011. (appendix 1) 8. Young JD, Leavitt JA. Lambert–Eaton myasthenic syndrome: ocular signs and symptoms. J Neuro-Ophthalmol. 2016;36(1):20–22.